Theravance Biopharma Inc. (TBPH)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
Q3  2024 | |||||
≡ | Seth Klarman - Baupost Group | Sell 100.00% | 4,200,021 | 1.01 | |
Q2  2024 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 36.31% | 2,394,105 | 0.58 | |
Q1  2024 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 11.12% | 825,100 | 0.21 | |
Q2  2023 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 28.79% | 3,000,000 | 0.56 | |
Q1  2023 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 8.76% | 1,000,000 | 0.19 | |
Q4  2022 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 14.90% | 2,000,000 | 0.38 | |
Q2  2022 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 1.64% | 224,107 | 0.03 | |
Q1  2022 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 0.12% | 16,835 | 0.00 | |
Q3  2020 | |||||
≡ | Seth Klarman - Baupost Group | Reduce 6.17% | 574,000 | 0.09 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.